ResearcherActive in the last 2 years

Jinlan Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-3419-5172; OpenAlex author ID A5101351356. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

Causal Links Between Antibody-Mediated Immune Responses and Pancreatic Cancer Risk. Last author DOI 10.2174/0118715303396420251007140802 ↗
The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study. First author DOI 10.1097/md.0000000000037797 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ling Zhang · 2 shared papers, 2024–2026 · strength 0.67
- Paper Causal Links Between Antibody-Mediated Immune Responses and Pancreatic Cancer Risk. DOI 10.2174/0118715303396420251007140802 ↗
- Paper The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study. DOI 10.1097/md.0000000000037797 ↗
Xinyun Zou · 1 shared paper, 2026 · strength 0.39
- Paper Causal Links Between Antibody-Mediated Immune Responses and Pancreatic Cancer Risk. DOI 10.2174/0118715303396420251007140802 ↗
Xinyun Zou · 1 shared paper, 2024 · strength 0.28
- Paper The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study. DOI 10.1097/md.0000000000037797 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.